74 related articles for article (PubMed ID: 21766697)
1. [Suppression of leptin and insulin signaling by SOCS3].
Yoshimura A
Nihon Rinsho; 2011 Jan; 69 Suppl 1():782-9. PubMed ID: 21766697
[No Abstract] [Full Text] [Related]
2. Attenuation of leptin and insulin signaling by SOCS proteins.
Howard JK; Flier JS
Trends Endocrinol Metab; 2006 Nov; 17(9):365-71. PubMed ID: 17010638
[TBL] [Abstract][Full Text] [Related]
3. Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3).
Yang Z; Hulver M; McMillan RP; Cai L; Kershaw EE; Yu L; Xue B; Shi H
PLoS One; 2012; 7(10):e47493. PubMed ID: 23115649
[TBL] [Abstract][Full Text] [Related]
4. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism.
Vilà L; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Hepatology; 2008 Nov; 48(5):1506-16. PubMed ID: 18924245
[TBL] [Abstract][Full Text] [Related]
6. SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells.
Piao L; Park J; Li Y; Shin S; Shin S; Kong G; Shrestha R; Tran Q; Hur GM; Kim JL; Park J
Int J Mol Med; 2014 May; 33(5):1364-70. PubMed ID: 24626642
[TBL] [Abstract][Full Text] [Related]
7. The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development.
Boyle K; Robb L
J Reprod Immunol; 2008 Jan; 77(1):1-6. PubMed ID: 17408753
[TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling 3 knockdown in the mediobasal hypothalamus: counterintuitive effects on energy balance.
de Backer MW; Brans MA; van Rozen AJ; van der Zwaal EM; Luijendijk MC; Garner KG; de Krom M; van Beekum O; la Fleur SE; Adan RA
J Mol Endocrinol; 2010 Nov; 45(5):341-53. PubMed ID: 20819948
[TBL] [Abstract][Full Text] [Related]
9. Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins.
Jamshidi Y; Snieder H; Wang X; Spector TD; Carter ND; O'Dell SD
Diabetologia; 2006 Feb; 49(2):306-10. PubMed ID: 16402267
[TBL] [Abstract][Full Text] [Related]
10. Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
Sachithanandan N; Fam BC; Fynch S; Dzamko N; Watt MJ; Wormald S; Honeyman J; Galic S; Proietto J; Andrikopoulos S; Hevener AL; Kay TW; Steinberg GR
Hepatology; 2010 Nov; 52(5):1632-42. PubMed ID: 20799351
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice.
Inagaki-Ohara K; Mayuzumi H; Kato S; Minokoshi Y; Otsubo T; Kawamura YI; Dohi T; Matsuzaki G; Yoshimura A
Oncogene; 2014 Jan; 33(1):74-84. PubMed ID: 23178499
[TBL] [Abstract][Full Text] [Related]
12. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity.
Mori H; Hanada R; Hanada T; Aki D; Mashima R; Nishinakamura H; Torisu T; Chien KR; Yasukawa H; Yoshimura A
Nat Med; 2004 Jul; 10(7):739-43. PubMed ID: 15208705
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of SOCS3 in the hypothalamic arcuate nucleus during seasonal body mass changes in the field vole, Microtus agrestis.
Król E; Tups A; Archer ZA; Ross AW; Moar KM; Bell LM; Duncan JS; Mayer C; Morgan PJ; Mercer JG; Speakman JR
J Neuroendocrinol; 2007 Feb; 19(2):83-94. PubMed ID: 17214870
[TBL] [Abstract][Full Text] [Related]
14. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and suppressors of cytokine signaling proteins.
Rønn SG; Billestrup N; Mandrup-Poulsen T
Diabetes; 2007 Feb; 56(2):541-8. PubMed ID: 17259405
[No Abstract] [Full Text] [Related]
16. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
[TBL] [Abstract][Full Text] [Related]
17. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
Riehle KJ; Campbell JS; McMahan RS; Johnson MM; Beyer RP; Bammler TK; Fausto N
J Exp Med; 2008 Jan; 205(1):91-103. PubMed ID: 18158318
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2.
Zeng B; Li H; Liu Y; Zhang Z; Zhang Y; Yang R
Cancer Res; 2008 Jul; 68(13):5397-404. PubMed ID: 18593942
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vector-mediated knockdown of SOCS3 in the hypothalamus protects against the development of diet-induced obesity in rats.
Liu ZJ; Bian J; Zhao YL; Zhang X; Zou N; Li D
Diabetes Obes Metab; 2011 Oct; 13(10):885-92. PubMed ID: 21554522
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes.
Tajmir P; Kwan JJ; Kessas M; Mozammel S; Sweeney G
J Cell Physiol; 2003 Oct; 197(1):122-30. PubMed ID: 12942548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
